ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+19.04%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
AUM
$151M
AUM Growth
+$151M
Cap. Flow
-$1.38M
Cap. Flow %
-0.91%
Top 10 Hldgs %
95.58%
Holding
19
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$60.3M 40.05%
6,068,125
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.41B
$24.6M 16.36%
1,025,000
VRNA
3
Verona Pharma
VRNA
$9.16B
$13.6M 9.04%
1,332,485
GLUE icon
4
Monte Rosa Therapeutics
GLUE
$296M
$12M 7.99%
1,472,331
ACRS icon
5
Aclaris Therapeutics
ACRS
$209M
$9.99M 6.63%
634,455
BMEA icon
6
Biomea Fusion
BMEA
$116M
$7.81M 5.19%
798,757
NUVB icon
7
Nuvation Bio
NUVB
$1.02B
$5.69M 3.78%
2,541,009
PSTX
8
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$3.68M 2.45%
1,043,267
ELEV
9
DELISTED
Elevation Oncology
ELEV
$3.2M 2.13%
2,834,910
OKUR
10
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$2.97M 1.97%
886,075
SPRB
11
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.65M 1.1%
1,205,511
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.23M 0.82%
288,571
MRKR icon
13
Marker Therapeutics
MRKR
$12M
$1.16M 0.77%
3,142,857
SYRE icon
14
Spyre Therapeutics
SYRE
$996M
$890K 0.59%
1,691,151
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$646K 0.43%
1,009,779
BCEL
16
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$609K 0.4%
387,653
TRML icon
17
Tourmaline Bio
TRML
$601M
$460K 0.31%
175,000
-507,923
-74% -$1.34M
ZSAN
18
DELISTED
Zosano Pharma Corporation
ZSAN
-77,663
Closed -$24K
NBRV
19
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-90,000
Closed -$16K